| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Production by Peripheral Blood and Mucosal CCR9+ T Lymphocytes1
Burns and Allen Research Institute, Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90048
The TNF-like cytokine TL1A augments IFN-
production by anti-CD3 plus anti-CD28 and IL-12/IL-18-stimulated peripheral blood (PB) T cells. However, only a small subset of PB T cells respond to TL1A stimulation with IFN- production. PB CCR9+ T cells represent a small subset of circulating T cells with mucosal T cell characteristics and a Th1/Tr1 cytokine profile. In the current study, we show that TL1A enhanced IFN- production by TCR- or CD2/CD28-stimulated CCR9+CD4+ PB T cells. However, TL1A had the most pronounced effect on augmenting IFN- production by IL-12/IL-18-primed CCR9+CD4+ PB T cells. TL1A enhanced both the percentage and the mean fluorescence intensity of IFN- in CCR9+CD4+ T cells as assessed by intracellular cytokine staining. IL-12 plus IL-18 up-regulated DR3 expression in CCR9+CD4+ T cells but had negligible effect on CCR9–CD4+ T cells. CCR9+CD4+ T cells isolated from the small intestine showed a 37- to 105-fold enhancement of IFN- production when TL1A was added to the IL-12/IL18 cytokine combination. Cell membrane-expressed TL1A was preferentially expressed in CCR9+CD4+ PB T cells, and a blocking anti-TL1A mAb inhibited IFN- production by cytokine-primed CCR9+CD4+ T cells by 
50%. Our data show that the TL1A/DR3 pathway plays a dominant role in the ultimate level of cytokine-induced IFN- production by CCR9+ mucosal and gut-homing PB T cells and could play an important role in Th1-mediated intestinal diseases, such as Crohn’s disease, where increased expression of IL-12, IL-18, TL1A, and DR3 converge in the inflamed intestinal mucosa.
This article has been cited by other articles:
|
|
 |
|
  B. P. Pappu, A. Borodovsky, T. S. Zheng, X. Yang, P. Wu, X. Dong, S. Weng, B. Browning, M. L. Scott, L. Ma, et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease J. Exp. Med., May 12, 2008; 205(5): 1049 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Cassatella, G. P. da Silva, I. Tinazzi, F. Facchetti, P. Scapini, F. Calzetti, N. Tamassia, P. Wei, B. Nardelli, V. Roschke, et al. Soluble TNF-Like Cytokine (TL1A) Production by Immune Complexes Stimulated Monocytes in Rheumatoid Arthritis J. Immunol., June 1, 2007; 178(11): 7325 - 7333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Prehn, L. S. Thomas, C. J. Landers, Q. T. Yu, K. S. Michelsen, and S. R. Targan The T Cell Costimulator TL1A Is Induced by Fc{gamma}R Signaling in Human Monocytes and Dendritic Cells J. Immunol., April 1, 2007; 178(7): 4033 - 4038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Saruta, Q. T. Yu, A. Avanesyan, P. R. Fleshner, S. R. Targan, and K. A. Papadakis Phenotype and Effector Function of CC Chemokine Receptor 9-Expressing Lymphocytes in Small Intestinal Crohn's Disease J. Immunol., March 1, 2007; 178(5): 3293 - 3300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-Y. Kim, K.-M. Toellner, A. White, F. M. McConnell, F. M. C. Gaspal, S. M. Parnell, E. Jenkinson, G. Anderson, and P. J. L. Lane Neonatal and Adult CD4+CD3- Cells Share Similar Gene Expression Profile, and Neonatal Cells Up-Regulate OX40 Ligand in Response to TL1A (TNFSF15). J. Immunol., September 1, 2006; 177(5): 3074 - 3081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bamias, M. Mishina, M. Nyce, W. G. Ross, G. Kollias, J. Rivera-Nieves, T. T. Pizarro, and F. Cominelli From the Cover: Role of TL1A and its receptor DR3 in two models of chronic murine ileitis PNAS, May 30, 2006; 103(22): 8441 - 8446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Young and M. G. Tovey TL1A: A mediator of gut inflammation PNAS, May 30, 2006; 103(22): 8303 - 8304. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
